ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Dianthus Therapeutics Inc

Dianthus Therapeutics Inc (DNTH)

84,11
-0,86
( -1,01% )
Aktualisiert: 16:43:39

Dianthus Therapeutics Inc (DNTH) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-01Dr. Simrat RandhawaExec. VP and Head of R&D-26,53k1,90MDerivative Exercise and Sale8,44 - 91,374,00k-
2026-05-08Ms. Paula SoteropoulosIndependent Director-599,0046,14kDerivative Exercise and Sale8,44 - 85,470,00-
2026-04-09Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer-8,22k591,80kDerivative Exercise and Sale17,88 - 89,840,00-
2026-03-31Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer-114,37k8,15MDerivative Exercise and Sale8,44 - 85,540,00-
2026-03-31Ms. Paula SoteropoulosIndependent Director-599,0042,93kDerivative Exercise and Sale8,44 - 80,110,00-
2026-03-24Ms. Paula SoteropoulosIndependent Director-27,59k1,92MDerivative Exercise and Sale8,44 - 78,050,00-
2026-03-16Mr. Marino GarciaPresident, CEO & Director65,29k499,97kDerivative Exercise and Retained Stock6,70 - 17,8865,29k-
2026-03-12Dr. Simrat RandhawaExec. VP and Head of R&D-33,83k2,14MDerivative Exercise and Sale8,44 - 81,480,00-
2026-03-12Mr. Marino GarciaPresident, CEO & Director-122,92k9,19MDerivative Exercise and Sale6,70 - 85,530,00-
2026-03-12Mr. Edward G. CarrSenior VP & CAO-43,68k2,67MDerivative Exercise and Sale17,88 - 85,530,00-
2025-12-04Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer-20,00k734,80kDerivative Exercise and Sale8,44 - 45,180,00-
2025-11-21Fairmount Funds Management LLCUnternehmen-1,17M46,22MVerkauf39,502,14M-35,38%
2025-11-13Dr. Simrat RandhawaExec. VP and Head of R&D-196,54k4,38MDerivative Exercise and Sale8,44 - 38,144,00k-
2025-09-11Fairmount Funds Management LLCUnternehmen600,00k19,80MKauf33,003,31M22,16%
2025-09-09Mr. Ryan SavitzExec. VP, CFO, Chief Business Officer & Treasurer-20,00k531,20kDerivative Exercise and Sale8,44 - 35,000,00-